Treatment of psychosis with a muscarinic m1 receptor ectopic activator
OwnerP. Conn, Marlene Jacobson +3inventors
InventorsP. Conn, Marlene Jacobson, Pierre Mallorga, Edward Scolnick, Cyrille Sur
Life of this patent
Estimating the term…
Abstract
A muscarinic M1 receptor ectopic activator, such as a muscarinic M1 receptor allosteric potentiator or a muscarinic M1 receptor ectopic agonist is useful, alone or in combination with other antipsychotic agents, for treating or preventing psychosis, such as a schizophrenic disorder or psychosis in Alzheimer's disease or bipolar disorder, for enhancing cognition and for neuropathic pain.
Claims20
A method for treating, controlling, ameliorating or reducing the risk of psychosis in a patient in need thereof that comprises administering to the patient a therapeutically effective amount of a muscarinic M1 receptor ectopic activator.
A method for enhancing cognition in a patient in need thereof that comprises administering to the patient a therapeutically effective amount of a muscarinic M1 receptor ectopic activator.
A method for treating, controlling, ameliorating or reducing the risk of Alzheimer's disease in a patient in need thereof that comprises administering to the patient a therapeutically effective amount of a muscarinic M1 receptor ectopic activator.
Dependencies are inferred from the claim text.